Formulation and characterization of folate receptor-targeted PEGylated liposome encapsulating bioactive compounds from Kappaphycus alvarezii for cancer therapy
- 24 February 2020
- journal article
- research article
- Published by Springer Nature in 3 Biotech
- Vol. 10 (3) , 1-18
Abstract
This study aimed to formulate and characterize the folate receptor-targeted PEGylated liposome encapsulating bioactive compounds from Kappaphycus alvarezii to enhance the anticancer activity. Twenty valued bioactive compounds (3-hydroxy benzoicacid, gallicacid, chlorogenicacid, cinnamicacid, artemiseole, hydrazine carbothioamide, etc.,) are confirmed from methanol extract of K. alvarezii using analytical techniques like HPLC and GC–MS. The delivery of bioactive compounds of K. alvarezii via naturally overexpressed folate receptor (FR) to FR-positive breast cancer cells was studied. FR targeted PEGylated liposome was constructed by modified thin-film hydration technique using FA-PEG-DSPE/cholesterol/DSPC (5:40:55) and bioactive compounds of K. alvarezii was encapsulated. Their morphology, size, shape, physiological stability and drug release kinetics were studied. The study reports of K. alvarezii extract-encapsulated PEGylated liposome showed spherical shaped particles with amorphous in nature. The mean diameter of K. alvarezii extract–encapsulated PEGylated and FA-conjugated PEGylated liposomes was found to be 110 ± 6 nm and 140 ± 5 nm, respectively. Based on the stability studies, it could be confirmed that FA-conjugated PEGylated liposome was highly stable in various physiological buffer medium. FA-conjugated PEGylated liposome can steadily release the bioactive compounds of K. alvarezii extract in acidic medium (pH 5.4). MTT assay demonstrated the concentration-dependent cytotoxicity against MCF-7 cells after 24 h with IC50 of 81 µg/mL. Also, PEGylated liposome enhanced the delivery of K. alvarezii extract in MCF-7 cells. After treatment, typical apoptotic morphology of condensed nuclei and distorted membrane bodies was picturized. Additionally, PEGylated liposome targets the mitochondria of MCF-7 cells and significantly increased the level of ROS and contributes to the damage of mitochondrial transmembrane potential. Hence, PEGylated liposome could positively deliver the bioactive compounds of K. alvarezii extract into FR-positive breast cancer cells (MCF-7) and exhibit great potential in anticancer therapy.Keywords
Funding Information
- Tamilnadu State Council For Science And Technology (Student Projects Scheme 2018-19, No: 039)
This publication has 61 references indexed in Scilit:
- Target delivery of MYCN siRNA by folate-nanoliposomes delivery system in a metastatic neuroblastoma modelCancer Cell International, 2013
- Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivoJournal of Controlled Release, 2012
- Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cellsApoptosis, 2011
- Anticancer Drugs from Marine Flora: An OverviewJournal of Oncology, 2010
- Release Kinetic Studies of Aspirin Microcapsules from Ethyl Cellulose, Cellulose Acetate Phthalate and their Mixtures by Emulsion Solvent Evaporation MethodScientia Pharmaceutica, 2010
- Nanoparticle-based targeted drug deliveryExperimental and Molecular Pathology, 2009
- Folic acid‐PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRIJournal of Biomedical Materials Research Part A, 2006
- Hydroxyzine- and Cetirizine-Loaded Liposomes: Effect of Duration of Thin Film Hydration, Freeze-Thawing, and Changing Buffer pH on Encapsulation and StabilityDrug Development and Industrial Pharmacy, 2005
- Targeting of the photocytotoxic compound AlPcS4 to hela cells by transferrin conjugated peg‐liposomesInternational Journal of Cancer, 2002
- Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Letters, 1990